Age, Biography and Wiki

Emmanuelle Charpentier (Emmanuelle Marie Charpentier) was born on 11 December, 1968 in Juvisy-sur-Orge, France, is a French microbiologist, biochemist and Nobel laureate. Discover Emmanuelle Charpentier's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is she in this year and how she spends money? Also learn how she earned most of networth at the age of 55 years old?

Popular As Emmanuelle Marie Charpentier
Occupation N/A
Age 55 years old
Zodiac Sign Sagittarius
Born 11 December, 1968
Birthday 11 December
Birthplace Juvisy-sur-Orge, France
Nationality France

We recommend you to check the complete list of Famous People born on 11 December. She is a member of famous with the age 55 years old group.

Emmanuelle Charpentier Height, Weight & Measurements

At 55 years old, Emmanuelle Charpentier height not available right now. We will update Emmanuelle Charpentier's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

She is currently single. She is not dating anyone. We don't have much information about She's past relationship and any previous engaged. According to our Database, She has no children.

Family
Parents Not Available
Husband Not Available
Sibling Not Available
Children Not Available

Emmanuelle Charpentier Net Worth

Her net worth has been growing significantly in 2023-2024. So, how much is Emmanuelle Charpentier worth at the age of 55 years old? Emmanuelle Charpentier’s income source is mostly from being a successful . She is from France. We have estimated Emmanuelle Charpentier's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income

Emmanuelle Charpentier Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia Emmanuelle Charpentier Wikipedia
Imdb

Timeline

1968

Emmanuelle Marie Charpentier (born 11 December 1968 ) is a French professor and researcher in microbiology, genetics, and biochemistry.

Born in 1968 in Juvisy-sur-Orge in France, Charpentier studied biochemistry, microbiology, and genetics at the Pierre and Marie Curie University (which became the Faculty of Science of Sorbonne University) in Paris.

1992

She was a graduate student at the Institut Pasteur from 1992 to 1995 and was awarded a research doctorate.

Charpentier's PhD work investigated molecular mechanisms involved in antibiotic resistance.

Her paternal grandfather was an Armenian who escaped to France during the Armenian genocide and met his wife in Marseille.

1993

Charpentier worked as a university teaching assistant at Pierre and Marie Curie University from 1993 to 1995 and as a postdoctoral fellow at the Institut Pasteur from 1995 to 1996.

1996

She moved to the US and worked as a postdoctoral fellow at Rockefeller University in New York from 1996 to 1997.

During this time, Charpentier worked in the lab of microbiologist Elaine Tuomanen.

Tuomanen's lab investigated how the pathogen Streptococcus pneumoniae utilizes mobile genetic elements to alter its genome.

Charpentier also helped to demonstrate how S. pneumoniae develops vancomycin resistance.

1997

Charpentier worked as an assistant research scientist at the New York University Medical Center from 1997 to 1999.

There she worked in the lab of Pamela Cowin, a skin-cell biologist interested in mammalian gene manipulation.

Charpentier published a paper exploring the regulation of hair growth in mice.

1999

She held the position of Research Associate at the St. Jude Children's Research Hospital and at the Skirball Institute of Biomolecular Medicine in New York from 1999 to 2002.

2002

After five years in the United States, Charpentier returned to Europe and became the lab head and a guest professor at the Institute of Microbiology and Genetics, University of Vienna, from 2002 to 2004.

2004

In 2004, Charpentier published her discovery of an RNA molecule involved in the regulation of virulence-factor synthesis in Streptococcus pyogenes.

From 2004 to 2006 she was lab head and an assistant professor at the Department of Microbiology and Immunobiology.

2006

In 2006 she became a privatdozentin (Microbiology) and received her habilitation at the Centre of Molecular Biology.

From 2006 to 2009 she worked as lab head and associate professor at the Max F. Perutz Laboratories.

Charpentier moved to Sweden and became lab head and associate professor at the Laboratory for Molecular Infection Medicine Sweden (MIMS), at Umeå University.

2008

She held the position of group leader from 2008 to 2013 and was visiting professor from 2014 to 2017.

2011

In 2011, Charpentier met Jennifer Doudna at a research conference in San Juan, Puerto Rico, and they began a collaboration.

Working with Doudna's laboratory, Charpentier's laboratory showed that Cas9 could be used to make cuts in any DNA sequence desired.

The method they developed involved the combination of Cas9 with easily created synthetic "guide RNA" molecules.

Synthetic guide RNA is a chimera of crRNA and tracrRNA; therefore, this discovery demonstrated that the CRISPR-Cas9 technology could be used to edit the genome with relative ease.

Researchers worldwide have employed this method successfully to edit the DNA sequences of plants, animals, and laboratory cell lines.

Since its discovery, CRISPR has revolutionized genetics by allowing scientists to edit genes to probe their role in health and disease and to develop genetic therapies with the hope that it will prove safer and more effective than the first generation of gene therapies.

2013

She moved to Germany to act as department head and W3 Professor at the Helmholtz Centre for Infection Research in Braunschweig and the Hannover Medical School from 2013 until 2015.

In 2013, Charpentier co-founded CRISPR Therapeutics and ERS Genomics along with Shaun Foy and Rodger Novak.

2014

In 2014 she became an Alexander von Humboldt Professor.

2015

As of 2015, she has been a director at the Max Planck Institute for Infection Biology in Berlin.

In 2015 Charpentier accepted an offer from the German Max Planck Society to become a scientific member of the society and a director at the Max Planck Institute for Infection Biology in Berlin.

2016

Since 2016, she has been an Honorary Professor at Humboldt University in Berlin; since 2018, she is the Founding and acting director of the Max Planck Unit for the Science of Pathogens.

2017

Charpentier retained her position as visiting professor at Umeå University until the end of 2017 when a new donation from the Kempe Foundations and the Knut and Alice Wallenberg Foundation allowed her to offer more young researchers positions within research groups of the MIMS Laboratory.

Charpentier is best known for her Nobel-winning work of deciphering the molecular mechanisms of a bacterial immune system, called CRISPR/Cas9, and repurposing it into a tool for genome editing.

In particular, she uncovered a novel mechanism for the maturation of a non-coding RNA which is pivotal in the function of CRISPR/Cas9.

Specifically, Charpentier demonstrated that a small RNA called tracrRNA is essential for the maturation of crRNA.

2018

In 2018, she founded an independent research institute, the Max Planck Unit for the Science of Pathogens.

2020

In 2020, Charpentier and American biochemist Jennifer Doudna of the University of California, Berkeley, were awarded the Nobel Prize in Chemistry "for the development of a method for genome editing" (through CRISPR).

This was the first science Nobel Prize ever won by two women only.